- Median is a leading provider of imaging services to the world’s top oncology pharma companies
- ASCO abstracts position Median as highly differentiated provider of AI-imaging services for oncology trials
- Median will host two presentation sessions to introduce its new solution for radiopharmaceutical image processing for oncology research at booth #11046
SOPHIA ANTIPOLIS, France–(BUSINESS WIRE)–Regulatory News:
Median Technologies (FR0011049824,…
Article Source
https://www.biospace.com/press-releases/median-technologies-to-showcase-icros-central-and-ai-powered-imaging-services-for-oncology-clinical-trials-at-asco-2025
